These inhibitory effects on PARP activity were significantly correlated to their cytostatic effects on UWB1.289, UWB1.289 + BRCA1, OVCAR-3 and SKOV-3 human ovarian cancer cells. The gene discussed is PARP1; the disease is ovarian cancer.